What happened, in summary

This Noxte update centered on a new worry during ongoing lung cancer treatment. A CT had raised concern for a bone lesion, and MRI confirmed a single focal lytic lesion in the left iliac bone. The report described it as suspicious for metastasis in the clinical context, while also noting that no other suspicious focal bone lesions were seen. The patient did not want a biopsy because his oncologist did not consider it necessary and because the result would not change the immediate plan. He would continue AZD9291 through the clinical trial and watch how both the main lung tumor and the bone lesion evolved. Radiotherapy was discussed as a possible way to treat the iliac lesion, but he chose to defer it because the pain was limited, controlled with the same analgesics used for the lung tumor, and radiation would not be curative. As of 18 September 2016, he was continuing protocol blood tests to monitor toxicity, with the next CT expected in November. Physically, he felt better than before the trial but still had chest pain, cough, breathing difficulty at times, and back or shoulder-blade-region pain depending on tumor position. Emotionally, the MRI result left him shaken but still trying to keep living.